Subscribe to newsletter Subscribe to newsletter Subscribe to newsletter Subscribe to newsletter Subscribe to newsletter Subscribe to newsletter
Reimbursement strategy

Market Access Strategy for Medical Devices in Europe

Strategic recommendations on the topic of market access pathways for medical devices and IVD tests

Learn more
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

Recent news and posts

Tags

Use tags to find relevant records
3D printed implants
Ablation methods
Allogeneic mesenchymal stem cells
Ambulatory ECG monitoring
Aortic abdominal aneurysm
Aortic root replacement
Arthroplasty
Arthroscopy
Assisted ventilation
Atherectomy
Austria
Autologous chondrocyte implantation
Automated external defibrillator
AV fistula
AV graft
Balloon kyphoplasty
Bariatric surgery
Baroreflex activation therapy
Barrett’s oesophagus
Belgium
Benign prostatic hyperplasia
Biopsy
Bone Conductive Hearing Device
Breast reconstruction
Bronchial thermoplasty
Burns
Caesarean section
Cancer
Capsule endoscopy
Carbon ion therapy
Cardiac ablation
Cardiac computer tomography
Cardiac pacemaker
Cardiac resynchronization therapy
Cardiac Resynchronization Therapy Defibrillator (CRT-D)
Cardiovascular devices
Cardiovascular procedures
Carotid endarterectomy
Cataract
Cell therapy
Cesarean section
Cholecystectomy
Chronic obstructive pulmonary disease
Chronic wounds
Clinical guidelines
Cochlear implants
Commissioning
Companion diagnostic tests
Computed tomography
Conditional reimbursement
Connected medical devices
Continuous glucose monitoring (CGM)
Coronary interventions
Coronary percutaneous revascularization procedures
Coronary procedures
Coronavirus
See all tags

The 2026 application window for changes in the CHOP Classification announced

In February 2026, the Swiss Federal Statistics Office (Bundesamt für Statistik, BFS) announced the timelines for the application window for changes to the Swiss Classification of Surgical Operations (CHOP), meaning the procedure will resume in 2026 after it was cancelled for 2025. The application window will open on June 1, 2026.

The interested parties (Swiss Medical Association (FMH), the Conference of the Cantonal Ministers of Public Health (GDK), Swiss Association of Hospitals (H+), SwissDRG, health insurance companies and their associations, and the Medical Tariff Commission (MTK) can submit applications until September 14, 2026.

The full details in German can be found here.

This news is just one of about 300 market access news collected by our team in the premium subscription service Market Access Monitor every week from more than 80 organizations. Access our paid service to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). Access is organized as an online Database and email alert formats. Contact us to get a free, three-month, no-obligation trial.

Tags
Switzerland
Procedure coding
Reimbursement application

The latest related news

12
Feb 2026

The application window for changes to the Swiss outpatient reimbursement system is open

From February 1 to April 30, 2026, the OAAT AG (the entity managing the new Swiss outpatient reimbursement system) is accepting applications for the modifications of the TARDOC and Outpatient flat rates. Submitted proposals will be reviewed within the annual tariff development process, validated by the OAAT Board of Directors, and subsequently submitted to the Federal Council for final approval and publication.
Read more
21
Jan 2026

The draft release of the DRG package for 2027 was published in the Netherlands

On December 19, 2025, the Dutch Healthcare Authority (NZa) published the draft release of the 2027 DRG package (RZ27a). Seven new procedure codes, one new diagnosis code, and one new supplementary payment (OZP) are expected to be implemented across in-vitro diagnostics, obstetrics and gynecology, gastroenterology, urology, and other technology groups.
Read more
07
Jan 2026

Swiss List of Analyses updated in January 2026

On December 3, 2025, the Swiss Federal Office of Public Health announced amendments to the Healthcare Benefit Ordinance, including its Annex 3 (the List of Analysis). The modifications include the creation of a new code for Dermatophytes testing by nucleic acid amplification.
Read more
05
Jan 2026

First device obtained regular reimbursement after the pre-LPPR scheme in France

On December 19, 2025, an order was issued registering the Symplicity Spyral renal denervation catheter in Title V of the List of Reimbursable Products and Services (LPPR), enabling add-on reimbursement for medical devices used in hospital settings. The Symplicity Spyral received a positive opinion for LPPR registration in December 2023, following transitional coverage under the French innovative payment scheme known as pre-LPPR since December 2022.
Read more